These novel therapies, including Semaglutide , Mounjaro , and another option, represent a important advancement in managing type 2 diabetes and assisting with weight management. They operate by imitating the body’s natural incretin GLP-1 , helping to control blood levels and lower cravings. Each drug has a few different characteristics and may be